Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.

Publication Year: 2019

DOI:
10.1007/s00535-019-01618-1

PMCID:
PMC6942586

PMID:
31482438

Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Dr. Mishima has no financial conflicts of interest to declare. Dr. Sartor receives research preclinical grant support from Janssen, Gusto Global, Vedanta, Seres and BiomX and is on Advisory Boards for Danone/Yakult, Second Genome, BiomX, Biomica and Qu Pharmaceuticals."

Evidence found in paper:

"Compliance with ethical standards: Conflict of interestDr. Mishima has no financial conflicts of interest to declare. Dr. Sartor receives research preclinical grant support from Janssen, Gusto Global, Vedanta, Seres and BiomX and is on Advisory Boards for Danone/Yakult, Second Genome, BiomX, Biomica and Qu Pharmaceuticals. Conflict of interest: Dr. Mishima has no financial conflicts of interest to declare. Dr. Sartor receives research preclinical grant support from Janssen, Gusto Global, Vedanta, Seres and BiomX and is on Advisory Boards for Danone/Yakult, Second Genome, BiomX, Biomica and Qu Pharmaceuticals."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025